SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Jasper Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update

REDWOOD CITY, Calif., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. NASDAQ:JSPR (“Jasper”), a clinical stage biotechnology company focused on the design and development of innovative therapies to treat immune-mediated diseases, today reported results for the fiscal quarter ended Septe…

JSPR

Related stories